SomaLogic is transforming healthcare by applying our proprietary protein-measurement technology to the development of new diagnostic tests that deliver a higher quality of life by detecting diseases at their earliest stages and monitoring general wellness. Their ultimate goal is the 'Wellness Chip,' a single cost-effective and reliable blood test for multiple diseases and conditions that will enable healthcare providers to precisely monitor each individual's state of health and wellness in real time.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
03/01/16 | $60,500,000 |
Visium Healthcare Partners | undisclosed |